Clinical Trial Update: Ondansetron for the Treatment of Methamphetamine Dependence - 1 [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating ondansetron for treating methamphetamine dependence has been completed, sponsored by NIDA.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amphetamine-related Disorders
• Methamphetamine Dependence

Drugs mentioned

• Ondansetron (ondansetron)

Snippet

Sponsor: National Institute on Drug Abuse (NIDA) | Conditions: Amphetamine-Related Disorders | Phase 2 | Status: COMPLETED